We first determined whether PG-CAT treatment improved lung antioxidant capacity by administering the first dose (2.84 mg/kg) 24 h prior to RSV inoculation and a second dose (2.84 mg/kg) 24 post-infection (p.i.). This evidence concerns the gene CAT and infection.